KRISHNA PHARMA LTD

Company Registration Number:
07187143 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

KRISHNA PHARMA LTD

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

KRISHNA PHARMA LTD

Balance sheet

As at 31 March 2025


Notes
2025
2024


£
£
Fixed assets
Intangible assets: 3 2,995,316 2,995,316
Tangible assets: 4 130,251 53,686
Investments: 5 6,178 6,178
Total fixed assets: 3,131,745 3,055,180
Current assets
Stocks: 85,681 100,681
Debtors: 6 184,533 181,750
Cash at bank and in hand: 303,778 244,191
Total current assets: 573,992 526,622
Creditors: amounts falling due within one year: 7 (965,106) (907,411)
Net current assets (liabilities): (391,114) (380,789)
Total assets less current liabilities: 2,740,631 2,674,391
Creditors: amounts falling due after more than one year: 8 (2,178,647) (2,230,400)
Total net assets (liabilities): 561,984 443,991
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 561,884 443,891
Shareholders funds: 561,984 443,991

The notes form part of these financial statements

KRISHNA PHARMA LTD

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 17 September 2025
and signed on behalf of the board by:

Name: R Patel
Status: Director

The notes form part of these financial statements

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

2025 2024
Average number of employees during the period 15 17

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Intangible Assets

Total
Cost £
At 01 April 2024 2,995,316
At 31 March 2025 2,995,316
Amortisation
At 01 April 2024 0
At 31 March 2025 0
Net book value
At 31 March 2025 2,995,316
At 31 March 2024 2,995,316

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Tangible Assets

Total
Cost £
At 01 April 2024 162,348
Additions 99,172
At 31 March 2025 261,520
Depreciation
At 01 April 2024 108,662
Charge for year 22,607
At 31 March 2025 131,269
Net book value
At 31 March 2025 130,251
At 31 March 2024 53,686

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

5. Fixed investments

INVESTMENT since the company was incorporated

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

6. Debtors

2025 2024
££
Debtors due after more than one year: 0 0

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

7. Creditors: amounts falling due within one year note

Bank Loans 9797 HP 8910 Trade Cred 841529 Tax and Social Security 12349 Other creditors 92521

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

8. Creditors: amounts falling due after more than one year note

Bank Loan 1640437 HP 25988 Other Creditors 512222